Improving the Sleep of Cancer Patients Using an Internet-Based Program
SHUTi-C
Evaluating Internet-Based Interventions for Insomnia in Cancer Patients
1 other identifier
interventional
22
1 country
1
Brief Summary
The purpose of this study is to determine whether an Internet-based program, Sleep Healthy Using the Internet (SHUTi, or "Shut-Eye"), can help to improve the sleep of people who are in remission from cancer and experiencing symptoms of insomnia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cancer
Started Jul 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2008
CompletedStudy Start
First participant enrolled
July 1, 2008
CompletedFirst Posted
Study publicly available on registry
July 16, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedFebruary 25, 2010
February 1, 2010
1.3 years
June 18, 2008
February 24, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Insomnia Severity Index (ISI)
prior to intervention, after SHUTi use, after Hypnosis use
Sleep Diary: Sleep Efficiency
prior to intervention, after SHUTi use, after Hypnosis use
Sleep Diary: Total Sleep Time
prior to intervention, after SHUTi use, after Hypnosis use
Secondary Outcomes (8)
Sleep Diary: Sleep Onset Latency (SOL)
prior to intervention, after SHUTi use, after Hypnosis use
Sleep Diary: Wake After Sleep Onset (WASO)
prior to intervention, after SHUTi use, after Hypnosis use
Sleep Diary: Number of Nighttime Awakenings
prior to intervention, after SHUTi use, after Hypnosis use
Hospital Depression and Anxiety Scale
prior to intervention, after SHUTi use, after Hypnosis use
Pain scale
prior to intervention, after SHUTi use, after Hypnosis use
- +3 more secondary outcomes
Study Arms (4)
ImmedSHUTi/ImmedHyp
EXPERIMENTALIn the first part of the trial, participants are assigned to the Immediate SHUTi group; that is, they receive access to the SHUTi program right away. In the second part of the trial (3 months later), participants are assigned to the Immediate Hypnosis group; that is, they receive access to the Hypnosis recordings right away.
ImmedSHUTi/DelayHyp
EXPERIMENTALIn the first part of the trial, participants are assigned to the Immediate SHUTi group; that is, they receive access to the SHUTi program right away. In the second part of the trial (3 months later), participants are assigned to the Delayed Hypnosis group; that is, they receive access to the Hypnosis recordings at the end of the study.
DelaySHUTi/ImmedHyp
EXPERIMENTALIn the first part of the trial, participants are assigned to the Delayed SHUTi group; that is, they receive access to the SHUTi program at the end of the study. In the second part of the trial (3 months later), participants are assigned to the Immediate Hypnosis group; that is, they receive access to the Hypnosis recordings right away.
DelaySHUTi/DelayHyp
NO INTERVENTIONIn the first part of the trial, participants are assigned to the Delayed SHUTi group; that is, they receive access to the SHUTi program at the end of the study. In the second part of the trial (3 months later), participants are assigned to the Delayed Hypnosis group; that is, they receive access to the Hypnosis recordings at the end of the study.
Interventions
SHUTi is an Internet program based on cognitive-behavioral therapy for insomnia (CBT-I). Users complete daily online sleep diaries in addition to receiving weekly access to six interactive "Cores" of information. As they progress through the program, users receive tailored instructions for how to improve their sleep.
Subjects listen to self-hypnosis recordings designed to improve their disturbed sleep.
Eligibility Criteria
You may qualify if:
- Age = At least 21 years old
- Regular access to the Internet, including e-mail
- Cancer patient
- Any type of cancer (EXCEPT non-melanoma skin cancer)
- In remission from any stage of cancer (active treatment completed at least one month prior to enrollment)
- Insomnia diagnosis (combined from DSM-IV and ICSD):
- Subjective complaints of poor sleep for at least 6 months
- Sleep difficulties ≥3 nights/week
- Difficulty falling asleep (≥30 minutes to fall asleep) OR
- Difficulty staying asleep (≥30 minutes awake in the middle of the night)
- ≤6.5 hours sleep/night
- Poor sleep causes marked distress or significant impairment in daytime functioning (e.g. fatigue, performance deficits, mood disturbance)
- Participant feels that the insomnia was caused/aggravated by cancer or cancer treatment
You may not qualify if:
- Having a sleep disorder other than insomnia (e.g. sleep apnea, RLS, narcolepsy, parasomnias)
- Having a medical condition other than cancer that causes insomnia
- Experiencing a psychiatric disturbance (major depression, psychosis)
- Experiencing substance abuse
- Currently undergoing psychotherapy or counseling
- Changing sleep/anxiety/depression medication within the past month
- Having an "unusual" sleep pattern
- Normal bedtime is after 2am OR
- Normal wake time is after 9am
- Working as a shift worker (that is, having a schedule that requires working through the night)
- Participants reports that she is pregnant or intending to get pregnant in the next 4 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Virginia Department of Psychiatry & Neurobehavioral Sciences
Charlottesville, Virginia, 22908, United States
Related Publications (1)
Savard J, Simard S, Ivers H, Morin CM. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol. 2005 Sep 1;23(25):6083-96. doi: 10.1200/JCO.2005.09.548.
PMID: 16135475BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lee M Ritterband, Ph.D.
University of Virginia
- PRINCIPAL INVESTIGATOR
Lora D Baum, Ph.D.
University of Virginia
- STUDY DIRECTOR
Elaine T Bailey, Ph.D.
University of Virginia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 18, 2008
First Posted
July 16, 2008
Study Start
July 1, 2008
Primary Completion
November 1, 2009
Study Completion
November 1, 2009
Last Updated
February 25, 2010
Record last verified: 2010-02